{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:19:05Z","timestamp":1781104745690,"version":"3.54.1"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bcp.2024.116571","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:16:35Z","timestamp":1729124195000},"page":"116571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P1","title":["Cardiometabolic effects of sacubitril\/valsartan in a rat model of heart failure with preserved ejection fraction"],"prefix":"10.1016","volume":"230","author":[{"given":"Sandra","family":"Mora\u00f1a-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xocas","family":"V\u00e1zquez-Abu\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3089-0684","authenticated-orcid":false,"given":"Alana","family":"Arag\u00f3n-Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Anido-Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Garc\u00eda-Seara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3scar","family":"Otero-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Rodr\u00edguez-Penas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Campos-Toimil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Otero-Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Pereira Morais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas N.","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia","family":"Sousa-Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas","family":"Falc\u00e3o-Pires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ram\u00f3n","family":"Gonz\u00e1lez-Juanatey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Feij\u00f3o-Band\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Lago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2024.116571_b0005","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2024.116571_b0010","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1002\/ehf2.14097","article-title":"Sacubitril\/valsartan in heart failure: efficacy and safety in and outside clinical trials","volume":"9","author":"Abdin","year":"2022","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.bcp.2024.116571_b0015","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/ejhf.1858","article-title":"Epidemiology of heart failure","volume":"22","author":"Groenewegen","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.bcp.2024.116571_b0020","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/cvr\/cvad100","article-title":"Cardiac lipid metabolism, mitochondrial function, and heart failure","volume":"119","author":"Da Dalt","year":"2023","journal-title":"Cardiovasc. Res."},{"issue":"2022","key":"10.1016\/j.bcp.2024.116571_b0025","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"AHA\/ACC\/HFSA guideline for the management of heart failure","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bcp.2024.116571_b0030","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1093\/cvr\/cvac166","article-title":"Cardiac metabolism in HFpEF: from fuel to signalling","volume":"118","author":"Capone","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2024.116571_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176170","article-title":"Sacubitril\/valsartan attenuates myocardial inflammation, hypertrophy, and fibrosis in rats with heart failure with preserved ejection fraction","volume":"961","author":"Shi","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116571_b0040","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jacbts.2021.07.010","article-title":"Relationship of nonalcoholic fatty liver disease and heart failure with preserved ejection fraction","volume":"6","author":"Salah","year":"2021","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.bcp.2024.116571_b0045","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021654","article-title":"Nonalcoholic fatty liver disease and risk of heart failure among medicare beneficiaries","volume":"10","author":"Fudim","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bcp.2024.116571_b0050","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/s41467-024-45440-7","article-title":"Targeting HDAC6 to treat heart failure with preserved ejection fraction in mice","volume":"15","author":"Ranjbarvaziri","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2024.116571_b0055","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.118.036259","article-title":"Mitochondrial dysfunction in heart failure with preserved ejection fraction","volume":"139","author":"Kumar","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2024.116571_b0060","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jacbts.2022.03.017","article-title":"Inefficient batteries in heart failure","volume":"7","author":"Schwartz","year":"2022","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.bcp.2024.116571_b0065","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3390\/ijms25021211","article-title":"Metabolic flexibility of the heart: the role of fatty acid metabolism in health, heart failure, and cardiometabolic diseases","volume":"25","author":"Actis Dato","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2024.116571_b0070","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac energy metabolism in heart failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2024.116571_b0075","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.molmed.2019.10.007","article-title":"Regulation of mitochondrial ATP production: Ca2+ signaling and quality control","volume":"26","author":"Boyman","year":"2020","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bcp.2024.116571_b0080","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvae006","article-title":"Mitochondrial fatty acid oxidation is the major source of cardiac adenosine triphosphate production in heart failure with preserved ejection fraction","author":"Sun","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2024.116571_b0085","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/jamacardio.2023.3216","article-title":"Health and economic evaluation of sacubitril-valsartan for heart failure management","volume":"8","author":"Bhatt","year":"2023","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.bcp.2024.116571_b0090","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1016\/j.jacc.2021.04.070","article-title":"Classification of heart failure according to ejection fraction: JACC review topic of the week","volume":"77","author":"Lam","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bcp.2024.116571_b0095","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2024.116571_b0100","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2024.116571_b0105","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1001\/jama.2021.18463","article-title":"PARALLAX investigators and committee members, effect of sacubitril\/valsartan vs standard medical therapies on plasma NT-proBNP concentration and submaximal exercise capacity in patients with heart failure and preserved ejection fraction","volume":"326","author":"Pieske","year":"2021","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.bcp.2024.116571_b0110","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0140-6736(12)61227-6","article-title":"The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial","volume":"380","author":"Solomon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2024.116571_b0115","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3390\/jcm13061572","article-title":"The efficacy and safety of sacubitril\/valsartan compared to valsartan in patients with heart failure and mildly reduced and preserved ejection fractions: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Kommu","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bcp.2024.116571_b0120","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12933-022-01545-1","article-title":"Effects of sacubitril\/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials","volume":"21","author":"Wijkman","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bcp.2024.116571_b0125","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/cpt.455","article-title":"Improved insulin sensitivity with angiotensin receptor neprilysin inhibition in individuals with obesity and hypertension","volume":"101","author":"Jordan","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2024.116571_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.892460","article-title":"Molecular mechanisms of sacubitril\/valsartan in cardiac remodeling","volume":"13","author":"Mustafa","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116571_b0135","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.3390\/ijms22073570","article-title":"Sacubitril\/valsartan improves diastolic function but not skeletal muscle function in a rat model of HFpEF","volume":"22","author":"Schauer","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2024.116571_b0140","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.cardfail.2020.08.009","article-title":"Effects of angiotensin-neprilysin inhibition in canines with experimentally induced cardiorenal syndrome","volume":"26","author":"Sabbah","year":"2020","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.bcp.2024.116571_b0145","doi-asserted-by":"crossref","unstructured":"National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, Guide for the Care and Use of Laboratory Animals, 8th ed., National Academies Press, Washington, D.C., 2011. doi: 10.17226\/12910.","DOI":"10.17226\/12910"},{"key":"10.1016\/j.bcp.2024.116571_b0150","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jacbts.2021.12.009","article-title":"Clinical phenotypes of heart failure with preserved ejection fraction to select preclinical animal models","volume":"7","author":"van Ham","year":"2022","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.bcp.2024.116571_b0155","doi-asserted-by":"crossref","first-page":"H1552","DOI":"10.1152\/ajpheart.00182.2019","article-title":"A novel method optimizing the normalization of cardiac parameters in small animal models: the importance of dimensional indexing","volume":"316","author":"Hagdorn","year":"2019","journal-title":"Am. J. Physiol.-Heart Circulatory Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116571_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-09094-z","article-title":"LCZ696 ameliorates doxorubicin-induced cardiomyocyte toxicity in rats","volume":"12","author":"Miyoshi","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2024.116571_b0165","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015640","article-title":"Sacubitril\/valsartan improves cardiac function and decreases myocardial fibrosis via downregulation of exosomal miR-181a in a rodent chronic myocardial infarction model","volume":"9","author":"Vaskova","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bcp.2024.116571_b0170","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12933-021-01270-1","article-title":"Sacubitril\/valsartan inhibits obesity-associated diastolic dysfunction through suppression of ventricular-vascular stiffness","volume":"20","author":"Aroor","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bcp.2024.116571_b0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/cvr\/cvaa110","article-title":"Towards standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC working group on myocardial function","volume":"117","author":"Zacchigna","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2024.116571_b0180","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/10742484211034253","article-title":"Chronic sildenafil therapy in the ZSF1 obese rat model of metabolic syndrome and heart failure with preserved ejection fraction","volume":"26","author":"Leite","year":"2021","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2024.116571_b0185","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cardfail.2017.12.010","article-title":"LCZ696 (Sacubitril\/Valsartan), an angiotensin-receptor neprilysin inhibitor, attenuates cardiac hypertrophy, fibrosis, and vasculopathy in a rat model of chronic kidney disease","volume":"24","author":"Suematsu","year":"2018","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.bcp.2024.116571_b0190","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13000-017-0671-y","article-title":"Automated quantification of steatosis: agreement with stereological point counting","volume":"12","author":"Homeyer","year":"2017","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.bcp.2024.116571_b0195","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3390\/biom10111585","article-title":"Digital image analysis of picrosirius red staining: a robust method for multi-organ fibrosis quantification and characterization","volume":"10","author":"Courtoy","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2024.116571_b0200","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3390\/antiox11050864","article-title":"Recent approaches to determine static and dynamic redox state-related parameters","volume":"11","author":"Mas-Bargues","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.bcp.2024.116571_b0205","first-page":"31","article-title":"High-Resolution FluoRespirometry and OXPHOS Protocols for Human Cells, Permeabilized Fibers from Small Biopsies of Muscle, and Isolated Mitochondria","volume":"Vol 1782","author":"Doerrier","year":"2018"},{"key":"10.1016\/j.bcp.2024.116571_b0210","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ab.2011.07.017","article-title":"Isolation of functional mitochondria from rat kidney and skeletal muscle without manual homogenization","volume":"418","author":"Gross","year":"2011","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bcp.2024.116571_b0215","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1021\/pr201223p","article-title":"Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression","volume":"11","author":"Barr","year":"2012","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bcp.2024.116571_b0220","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jprot.2015.01.019","article-title":"Enhancing metabolomics research through data mining","volume":"127","author":"Mart\u00ednez-Arranz","year":"2015","journal-title":"J. Proteomics"},{"key":"10.1016\/j.bcp.2024.116571_b0225","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1093\/eurheartj\/ehab499","article-title":"Sacubitril\u2013valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction","volume":"42","author":"Jackson","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bcp.2024.116571_b0230","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s42826-023-00179-y","article-title":"Shikimic acid recovers diarrhea and its complications in SD rats fed lactose diet to induce diarrhea","volume":"39","author":"Koriem","year":"2023","journal-title":"Lab. Anim. Res."},{"key":"10.1016\/j.bcp.2024.116571_b0235","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cardfail.2020.04.011","article-title":"Sacubitril\/valsartan improves left ventricular function in chronic pressure overload independent of intact cyclic guanosine monophosphate-dependent protein kinase I alpha signaling","volume":"26","author":"Tam","year":"2020","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.bcp.2024.116571_b0240","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jcmg.2018.12.034","article-title":"Diastolic dysfunction and heart failure with preserved ejection fraction","volume":"13","author":"Obokata","year":"2020","journal-title":"J. Am. Coll. Cardiol. Img."},{"key":"10.1016\/j.bcp.2024.116571_b0245","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.600953","article-title":"Sacubitril\/valsartan reduces fibrosis and alleviates high-salt diet-induced HFpEF in rats","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116571_b0250","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001122","article-title":"Supervised exercise training for chronic heart failure with preserved ejection fraction: a scientific statement from the American Heart Association and American College of Cardiology","volume":"147","author":"Sachdev","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2024.116571_b0255","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.cardfail.2019.09.008","article-title":"Interaction between sacubitril and valsartan in preventing heart failure induced by aortic valve insufficiency in rats","volume":"25","author":"Maslov","year":"2019","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.bcp.2024.116571_b0260","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijcard.2017.10.074","article-title":"Sacubitril\/valsartan and short-term changes in the 6-minute walk test: a pilot study","volume":"252","author":"Beltr\u00e1n","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bcp.2024.116571_b0265","doi-asserted-by":"crossref","first-page":"H289","DOI":"10.1152\/ajpheart.00579.2018","article-title":"Synergy between sacubitril and valsartan leads to hemodynamic, antifibrotic, and exercise tolerance benefits in rats with preexisting heart failure","volume":"316","author":"Maslov","year":"2019","journal-title":"Am. J. Physiol.-Heart Circulatory Physiol."},{"key":"10.1016\/j.bcp.2024.116571_b0270","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.3390\/nu13072230","article-title":"Effect of dietary strategies on respiratory quotient and its association with clinical parameters and organ fat loss: a randomized controlled trial","volume":"13","author":"Goldenshluger","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.bcp.2024.116571_b0275","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/CIRCHEARTFAILURE.114.001785","article-title":"Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy","volume":"8","author":"von Lueder","year":"2015","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.bcp.2024.116571_b0280","doi-asserted-by":"crossref","first-page":"14654","DOI":"10.1038\/s41598-022-18860-y","article-title":"Sacubitril\/valsartan (LCZ696) ameliorates hyperthyroid-induced cardiac hypertrophy in male rats through modulation of miR-377, let-7 b, autophagy, and fibrotic signaling pathways","volume":"12","author":"Khamis","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2024.116571_b0285","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jacbts.2020.07.006","article-title":"Differential effects of sacubitril\/valsartan on diastolic function in mice with obesity-related metabolic heart disease","volume":"5","author":"Croteau","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.bcp.2024.116571_b0290","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012673","article-title":"Glucose metabolism in cardiac hypertrophy and heart failure","volume":"8","author":"Tran","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bcp.2024.116571_b0295","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S2213-8587(17)30087-6","article-title":"Effect of sacubitril\/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial","volume":"5","author":"Seferovic","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.bcp.2024.116571_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110596","article-title":"The role of sacubitril\/valsartan in the treatment of chronic heart failure with reduced ejection fraction in hypertensive patients with comorbidities: from clinical trials to real-world settings","volume":"130","author":"Mazza","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2024.116571_b0305","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1177\/1932296818785644","article-title":"Reduction of insulin requirement after starting treatment with sacubitril\/valsartan in a patient with diabetes treated with continuous subcutaneous insulin infusion (CSII): a case report","volume":"12","author":"Gamarra","year":"2018","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.bcp.2024.116571_b0310","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.3390\/biomedicines10112863","article-title":"The role of NF-\u03baB and Bax\/Bcl-2\/caspase-3 signaling pathways in the protective effects of sacubitril\/valsartan (Entresto) against HFD\/STZ-induced diabetic kidney disease","volume":"10","author":"Mohany","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.bcp.2024.116571_b0315","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.7150\/ijms.49373","article-title":"Angiotensin II receptor Neprilysin inhibitor (LCZ696) compared to Valsartan attenuates Hepatotoxicity in STZ-induced hyperglycemic rats","volume":"17","author":"Alqahtani","year":"2020","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.bcp.2024.116571_b0320","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12933-019-0847-8","article-title":"The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat","volume":"18","author":"Habibi","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bcp.2024.116571_b0325","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.935390","article-title":"Association of metabolic dysfunction-associated fatty liver disease with left ventricular diastolic function and cardiac morphology","volume":"13","author":"Peng","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bcp.2024.116571_b0330","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.3390\/nu15061483","article-title":"Different dietary approaches, non-alcoholic fatty liver disease and cardiovascular disease: a literature review","volume":"15","author":"Torres-Pe\u00f1a","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.bcp.2024.116571_b0335","doi-asserted-by":"crossref","first-page":"8474","DOI":"10.1038\/s41467-023-44143-9","article-title":"Mtfp1 ablation enhances mitochondrial respiration and protects against hepatic steatosis","volume":"14","author":"Patitucci","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2024.116571_b0340","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.3390\/nu15224757","article-title":"The role of epigenetic control of mitochondrial (Dys)function in MASLD onset and progression","volume":"15","author":"Caputo","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.bcp.2024.116571_b0345","article-title":"Mitochondrial dysfunction: a promising therapeutic target for liver diseases","volume":"11","author":"Chen","year":"2024","journal-title":"Genes Dis."},{"key":"10.1016\/j.bcp.2024.116571_b0350","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.yjmcc.2020.05.008","article-title":"A directed network analysis of the cardiome identifies molecular pathways contributing to the development of HFpEF","volume":"144","author":"Summer","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bcp.2024.116571_b0355","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1161\/CIRCRESAHA.123.322654","article-title":"Mitochondrial GSNOR alleviates cardiac dysfunction via ANT1 denitrosylation","volume":"133","author":"Tang","year":"2023","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2024.116571_b0360","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1038\/s44318-024-00132-2","article-title":"Functional diversity among cardiolipin binding sites on the mitochondrial ADP\/ATP carrier","volume":"43","author":"Senoo","year":"2024","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2024.116571_b0365","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0014-5793(97)01563-9","article-title":"Muscle\/heart isoform of mitochondrial adenine nucleotide translocase (ANT1) is transiently expressed during perinatal development in rat liver","volume":"421","author":"Grado","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2024.116571_b0370","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0005-2736(98)00245-4","article-title":"Transcription of the adenine nucleotide translocase isoforms in various types of tissues in the rat","volume":"1417","author":"D\u00f6rner","year":"1999","journal-title":"Biochimica et Biophysica Acta (BBA) - Biomembranes"},{"key":"10.1016\/j.bcp.2024.116571_b0375","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/nature02816","article-title":"Dual role for the ADP\/ATP translocator?","volume":"430","author":"Halestrap","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2024.116571_b0380","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1080\/10408398.2017.1353479","article-title":"Nutrition, inflammation and liver-spleen axis","volume":"58","author":"Barrea","year":"2018","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.bcp.2024.116571_b0385","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/pharmaceutics12040320","article-title":"Dual angiotensin receptor and neprilysin inhibitor ameliorates portal hypertension in portal hypertensive rats","volume":"12","author":"Hsu","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2024.116571_b0390","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/jcpt.12408","article-title":"In vitro and clinical evaluation of OATP-mediated drug interaction potential of sacubitril\/valsartan (LCZ696)","volume":"41","author":"Ayalasomayajula","year":"2016","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.bcp.2024.116571_b0395","doi-asserted-by":"crossref","first-page":"27909","DOI":"10.1038\/srep27909","article-title":"Structure of neprilysin in complex with the active metabolite of sacubitril","volume":"6","author":"Schiering","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2024.116571_b0400","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s40262-017-0543-3","article-title":"Clinical pharmacokinetics of sacubitril\/valsartan (LCZ696): a novel angiotensin receptor-neprilysin inhibitor","volume":"56","author":"Ayalasomayajula","year":"2017","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bcp.2024.116571_b0405","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1093\/cvr\/cvac120","article-title":"Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets","volume":"118","author":"Borlaug","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2024.116571_b0410","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/ejhf.1956","article-title":"Regional adiposity and heart failure with preserved ejection fraction","volume":"22","author":"Rao","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.bcp.2024.116571_b0415","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/nm.3994","article-title":"Microbiota depletion promotes browning of white adipose tissue and reduces obesity","volume":"21","author":"Su\u00e1rez-Zamorano","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2024.116571_b0420","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ncb3122","article-title":"Rapid depot-specific activation of adipocyte precursor cells at the onset of obesity","volume":"17","author":"Jeffery","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bcp.2024.116571_b0425","first-page":"23","article-title":"Deciphering white adipose tissue heterogeneity","volume":"8","author":"Luong","year":"2019","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.bcp.2024.116571_b0430","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/jpp\/rgad012","article-title":"The dual inhibitor Sacubitril-valsartan ameliorate high-fat high-fructose-induced metabolic disorders in rats superiorly compared to valsartan only","volume":"75","author":"Abo-khookh","year":"2023","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116571_b0435","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.2337\/db11-1466","article-title":"B-type natriuretic peptide modulates ghrelin, hunger, and satiety in healthy men","volume":"61","author":"Vila","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2024.116571_b0440","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/s41467-024-45436-3","article-title":"Secretin-dependent signals in the ventromedial hypothalamus regulate energy metabolism and bone homeostasis in mice","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2024.116571_b0445","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.cell.2018.10.016","article-title":"Secretin-activated brown fat mediates prandial thermogenesis to induce satiation","volume":"175","author":"Li","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2024.116571_b0450","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022069","article-title":"Effects of sacubitril\/valsartan on serum lipids in heart failure with preserved ejection fraction","volume":"10","author":"Selvaraj","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bcp.2024.116571_b0455","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/CIRCULATIONAHA.122.061846","article-title":"Myocardial metabolomics of human heart failure with preserved ejection fraction","volume":"147","author":"Hahn","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2024.116571_b0460","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.011107","article-title":"Empagliflozin improves diastolic function in HFpEF by restabilizing the mitochondrial respiratory chain","volume":"17","author":"Schauer","year":"2024","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.bcp.2024.116571_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113677","article-title":"Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats","volume":"170","author":"Arag\u00f3n-Herrera","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116571_b0470","article-title":"Transcriptional analysis reveals that the intracellular lipid accumulation impairs gene expression profiles involved in insulin response-associated cardiac functionality","author":"Dato","year":"2023","journal-title":"Res. Sq. Preprint"},{"key":"10.1016\/j.bcp.2024.116571_b0475","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1021\/acs.jmedchem.2c02103","article-title":"Inhibitory effects of LRP1-based immunotherapy on cardiac extracellular matrix biophysical alterations induced by hypercholesterolemia","volume":"66","author":"Samouillan","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2024.116571_b0480","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.biocel.2014.09.005","article-title":"Cardiomyocyte intracellular cholesteryl ester accumulation promotes tropoelastin physical alteration and degradation","volume":"55","author":"Samouillan","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bcp.2024.116571_b0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113270","article-title":"Targeting cholesteryl ester accumulation in the heart improves cardiac insulin response","volume":"152","author":"Actis Dato","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2024.116571_b0490","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.3390\/ijms22136915","article-title":"Activated Alpha-2 macroglobulin improves insulin response via LRP1 in lipid-loaded HL-1 cardiomyocytes","volume":"22","author":"Actis Dato","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2024.116571_b0495","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.cardfail.2015.10.003","article-title":"Altered metabolic profile with sodium-restricted dietary approaches to stop hypertension diet in hypertensive heart failure with preserved ejection fraction","volume":"21","author":"Mathew","year":"2015","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.bcp.2024.116571_b0500","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jnutbio.2017.04.004","article-title":"Murine diet-induced obesity remodels cardiac and liver mitochondrial phospholipid acyl chains with differential effects on respiratory enzyme activity","volume":"45","author":"Sullivan","year":"2017","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.bcp.2024.116571_b0505","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1210\/en.2012-1835","article-title":"Obesity-related alterations in cardiac lipid profile and nondipping blood pressure pattern during transition to diastolic dysfunction in male db\/db mice","volume":"154","author":"DeMarco","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2024.116571_b0510","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1073\/pnas.0630588100","article-title":"Triglyceride accumulation protects against fatty acid-induced lipotoxicity","volume":"100","author":"Listenberger","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bcp.2024.116571_b0515","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/cvr\/cvaa319","article-title":"The role of CD36 in cardiovascular disease","volume":"118","author":"Shu","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2024.116571_b0520","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1152\/physrev.00011.2023","article-title":"CD36 as a gatekeeper of myocardial lipid metabolism and therapeutic target for metabolic disease","volume":"104","author":"Glatz","year":"2024","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2024.116571_b0525","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211314","article-title":"CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate","volume":"219","author":"Chen","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2024.116571_b0530","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1007\/s00125-007-0735-8","article-title":"Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification","volume":"50","author":"Ouwens","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.bcp.2024.116571_b0535","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.plefa.2016.06.002","article-title":"Molecular mechanism of lipid-induced cardiac insulin resistance and contractile dysfunction","volume":"136","author":"Liu","year":"2018","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.bcp.2024.116571_b0540","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.bbalip.2016.03.018","article-title":"The role of CD36 in the regulation of myocardial lipid metabolism","volume":"1861","author":"Kim","year":"2016","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"key":"10.1016\/j.bcp.2024.116571_b0545","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12933-015-0234-z","article-title":"Cardiospecific CD36 suppression by lentivirus-mediated RNA interference prevents cardiac hypertrophy and systolic dysfunction in high-fat-diet induced obese mice","volume":"14","author":"Zhang","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bcp.2024.116571_b0550","doi-asserted-by":"crossref","first-page":"27460","DOI":"10.1038\/srep27460","article-title":"Cinnamaldehyde and allopurinol reduce fructose-induced cardiac inflammation and fibrosis by attenuating CD36-mediated TLR4\/6-IRAK4\/1 signaling to suppress NLRP3 inflammasome activation","volume":"6","author":"Kang","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224005719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224005719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T03:04:09Z","timestamp":1732849449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224005719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":110,"alternative-id":["S0006295224005719"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116571","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiometabolic effects of sacubitril\/valsartan in a rat model of heart failure with preserved ejection fraction","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116571"}}